Synergy Pharmaceuticals Inc (SGYP)

5.51
0.25 4.30
NASDAQ : Health Care
Prev Close 5.76
Open 5.69
Day Low/High 5.43 / 5.79
52 Wk Low/High 2.50 / 9.76
Volume 3.60M
Avg Volume 4.83M
Exchange NASDAQ
Shares Outstanding 179.95M
Market Cap 1.06B
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Synergy Pharmaceuticals Secures Approval for Linzess Competitor

Synergy Pharmaceuticals Secures Approval for Linzess Competitor

New bowel drug Trulance will be available for patients later this quarter.

Futures, Asia Mixed as Investors Ponder the New President

Futures, Asia Mixed as Investors Ponder the New President

Many are ready to seal in gains as Donald Trump becomes the 45th president of these United States.

Biotech Sector to See M&A, Earnings Action

Biotech Sector to See M&A, Earnings Action

Deals already are popping up, and we'll soon have earnings reports from the industry giants.

Western Digital, Twilio, AT&T: 'Mad Money' Lightning Round (Friday 1/6/17)

Western Digital, Twilio, AT&T: 'Mad Money' Lightning Round (Friday 1/6/17)

Jim Cramer is bullish on Western Digital, Twilio, Salesforce.com and AT&T.

Health Care, Banks Lead Game Strategy for Next Week: Cramer's 'Mad Money' Recap (Friday 1/6/17)

Health Care, Banks Lead Game Strategy for Next Week: Cramer's 'Mad Money' Recap (Friday 1/6/17)

Jim Cramer says he's focusing on health-care companies that will break news that moves stocks.

Biotech Poised for Rebound

Biotech Poised for Rebound

If M&A picks up and Trump doesn't tweet about excessively high drug prices, there should be bounce.

Biotech Poised for Rebound

Biotech Poised for Rebound

If M&A picks up and Trump doesn't tweet about excessively high drug prices, there should be bounce.

How to Trade the Week's Most Active Stocks -- Micron, Nvidia, Synergy Pharma and More

How to Trade the Week's Most Active Stocks -- Micron, Nvidia, Synergy Pharma and More

Here's a technical look on how to trade some of the most active stocks on the market this week.

Futures Mixed Ahead of Holiday Weekend; Asia Opened Lower

Futures Mixed Ahead of Holiday Weekend; Asia Opened Lower

Futures follow market retreats as investors ponder trade and look forward to Christmas.

Synergy Pharmaceuticals Announces Positive Results In Second Phase 3 Trial Of Plecanatide In Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Synergy Pharmaceuticals Announces Positive Results In Second Phase 3 Trial Of Plecanatide In Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced positive top-line results from the second of two pivotal phase 3 clinical trials evaluating the efficacy and safety of plecanatide, an investigational once-daily...

First Week of February 2017 Options Trading For Synergy Pharmaceuticals (SGYP)

First Week of February 2017 Options Trading For Synergy Pharmaceuticals (SGYP)

Investors in Synergy Pharmaceuticals Inc saw new options become available this week, for the February 2017 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SGYP options chain for the new February 2017 contracts and identified one put and one call contract of particular interest.

Synergy Pharmaceuticals Announces Positive Results In First Phase 3 Trial Of Plecanatide In Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Synergy Pharmaceuticals Announces Positive Results In First Phase 3 Trial Of Plecanatide In Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced positive top-line results from the first of two pivotal phase 3 clinical trials evaluating the efficacy and safety of plecanatide, an investigational once-daily...

4 Promising Small Biotechs to Watch in 2017

4 Promising Small Biotechs to Watch in 2017

Veterinary drug play Aratana Therapeutics is among the potential solid performers next year.

First Week of July 2017 Options Trading For Synergy Pharmaceuticals (SGYP)

First Week of July 2017 Options Trading For Synergy Pharmaceuticals (SGYP)

Investors in Synergy Pharmaceuticals Inc saw new options begin trading this week, for the July 2017 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Synergy Pharmaceuticals To Present At Jefferies 2016 London Healthcare Conference

Synergy Pharmaceuticals To Present At Jefferies 2016 London Healthcare Conference

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced the company will present a corporate update at the Jefferies London Healthcare Conference on Wednesday, November 16, 2016 at 8:00 a.

Synergy Pharmaceuticals Reports Third Quarter 2016 Financial Results And Business Update

Synergy Pharmaceuticals Reports Third Quarter 2016 Financial Results And Business Update

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today reported its financial results and business update for...

Synergy Pharmaceuticals Becomes Oversold (SGYP)

Synergy Pharmaceuticals Becomes Oversold (SGYP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Short Interest Makes 10.6% Move For SGYP

Short Interest Makes 10.6% Move For SGYP

The most recent short interest data has been released for the 10/14/2016 settlement date, which shows a 2,623,458 share increase in total short interest for Synergy Pharmaceuticals Inc , to 27,315,643, an increase of 10.62% since 09/30/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

First Week of SGYP December 16th Options Trading

First Week of SGYP December 16th Options Trading

Investors in Synergy Pharmaceuticals Inc saw new options become available this week, for the December 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SGYP options chain for the new December 16th contracts and identified one put and one call contract of particular interest.

Synergy Pharmaceuticals Presents Long-Term Data For Plecanatide In Chronic Idiopathic Constipation At The American College Of Gastroenterology (ACG) Annual Scientific Meeting

Synergy Pharmaceuticals Presents Long-Term Data For Plecanatide In Chronic Idiopathic Constipation At The American College Of Gastroenterology (ACG) Annual Scientific Meeting

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today presented new long-term safety data of plecanatide, its investigational, orally-administered compound currently being evaluated by the U.

Lack of Catalysts Keeps Analysts Away From Pfizer

Lack of Catalysts Keeps Analysts Away From Pfizer

Pfizer may not be the best investment in coming months, as doubts surface about the company's near-term prospects in the absence of M&A.

Synergy Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Synergy Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced that the independent Compensation Committee of the Board of Directors of Synergy approved the grant of an inducement stock option to purchase 50,000 shares of...

Synergy Pharmaceuticals Announces New Plecanatide Data Presentations At Upcoming Scientific Meeting And Provides Update On IBS-C Program

Synergy Pharmaceuticals Announces New Plecanatide Data Presentations At Upcoming Scientific Meeting And Provides Update On IBS-C Program

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced that the company will present new data on plecanatide, an investigational compound for the treatment of chronic idiopathic constipation (CIC) and irritable bowel...

Synergy Pharmaceuticals To Present At OctoberINVESTfest 2016

Synergy Pharmaceuticals To Present At OctoberINVESTfest 2016

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced the company will present at the OctoberINVESTfest Conference on Wednesday, September 28, 2016 at 11:30 a.

First Week of SGYP November 18th Options Trading

First Week of SGYP November 18th Options Trading

Investors in Synergy Pharmaceuticals Inc saw new options become available this week, for the November 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SGYP options chain for the new November 18th contracts and identified one put and one call contract of particular interest.

Bought Aerie Earlier? Congratulations

Bought Aerie Earlier? Congratulations

An update on some recent small biotech recommendations.